http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View More Recent Stories
-
Veracyte to Expand Patient Access to the Afirma® Gene Expression Classifier In Thyroid Cancer Diagnosis Through Agreement with Quest Diagnostics
-
Quest Diagnostics Partners With Montefiore Health System to Deliver High-Value, Innovative Laboratory Services
-
Fit Female College Athletes More Prone to Overreaching than Less Fit Ones, Putting Performance at Risk, Finds New Research Presented at American College of Sports Medicine Annual Meeting
-
Quest Diagnostics to Showcase Its Advanced Healthcare Information Technology Solutions at HIMSS16 Under its New Quanum™ Brand
-
New York Giants Incorporate Sports Science from Quest Diagnostics into Training
-
Quest Diagnostics' ExamOne Life Insurance Testing Business to Acquire Superior Mobile Medics
-
Quest Diagnostics Introduces Dako's PD-L1 Complementary Diagnostic Test to Support Bristol-Myers Squibb's OPDIVO® Anti-PD-1 Therapy for Non-squamous Non-small Cell Lung Cancer
-
Testing for More Cystic Fibrosis Mutations than Recommended by Current Medical Guidelines May Identify A Greater Number of Potential Carriers, Finds Study Presented at 2015 ASHG Annual Meeting
-
FDA Clears the Focus Diagnostics Simplexa™ Flu A/B & RSV Direct Test to Include 53 New Virus Strains for the 2015-2016 Flu Season
-
Quest Diagnostics Introduces Dako's PD-L1 Companion Diagnostic for KEYTRUDA®, Merck's Anti-PD-1 Therapy for Metastatic Non-Small Cell Lung Cancer Whose Tumors Express PD-L1 with Disease Progression O
-
Focus Diagnostics Receives FDA Clearance to Add Genital Swab Claim to Moderate Complexity Simplexa™ HSV 1 & 2 Direct Molecular Test
-
Quest Diagnostics Completes Acquisition of MemorialCare Health System's Laboratory Outreach Service Business in Southern California
-
Quest Diagnostics Collaborates with Perinatal Quality Foundation on National Initiative to Advance Clinically Appropriate Noninvasive Prenatal Screening
-
Quest Diagnostics to Acquire MemorialCare Health System's Laboratory Outreach Service Business
-
UPDATE: 'Optionshawk' Tweet on Quest Diagnostics (DGX) Taken Off Twitter - Bloomberg
-
Streetinsider.com's Hot Lunchtime Reads 5/22: (DGX) (AAPL) (AWR) (DE)
-
Quest Diagnostics and Inserm Launch Multinational BRCA Gene Datashare Initiative, with LabCorp as First Participant, to Improve the Detection of Inherited Risk of Breast and Ovarian Cancers
-
FDA Clears the Simplexa™ Group A Strep Direct Test from Focus Diagnostics, a Quest Diagnostics Business
-
HPV-Only Screening Misses More Cervical Cancers in Women 30 and Older Than Pap-Only or Pap-HPV Co-testing, Finds National Study
-
Quest Diagnostics to Launch Interactive Insights and IntelliTest Interactive Reports and Health Data Analytics Tools at HIMSS 2015
-
Quest Diagnostics Recognizes Five Strategic Partners with Supplier Excellence Awards
-
Quintiles and Quest Diagnostics to Form Joint Venture to Provide Global Clinical Trials Laboratory Services
-
Diabetes Diagnoses Surge in States that Expanded Medicaid Under the Affordable Care Act
-
Quest Diagnostics Announces Early Tender Date Results of Cash Tender Offers for Up to $250 Million Combined Aggregate Principal Amount of Certain of its Outstanding Notes
-
Quest Diagnostics Announces Pricing of Cash Tender Offers for Up to $250 Million Combined Aggregate Principal Amount of Certain of its Outstanding Notes
-
Quest Diagnostics to Enhance Diagnosis of Pediatric Neurological Disorders with Exclusive Whole Exome Sequencing from Personalis
-
Quest Diagnostics Announces Amendments to the Prices Offered in its Previously Announced Cash Tender Offer for Up to $250 Million Combined Aggregate Principal Amount of Certain of its Outstanding Note
-
Quest Diagnostics Incorporated Announces Proposed Senior Notes Offering
-
Quest Diagnostics Commences Cash Tender Offer for Up to $250 Million Combined Aggregate Principal Amount of Certain of its Outstanding Notes
-
Notable 52-Week Highs and Lows of the Day 12/13: (ADBE) (AER) (NLSN) High; (LULU) (AVEO) (DGX) Low

